Scenario Breakdown of Revenue (2025)
| S.No. |
Ticker |
Company |
Market Cap |
P/E |
P/S |
Total Debt (Qtr) |
| 1 |
NVS
|
Novartis Ag |
110,466,237.30 Bn |
25.37 Mn |
2.11 Mn |
- |
| 2 |
GSK
|
GSK plc |
92,553,268.41 Bn |
11.78 Mn |
2.11 Mn |
-26.01 Bn |
| 3 |
LLY
|
ELI LILLY & Co |
900.54 Bn |
0.00 Mn |
0.00 Mn |
43.37 Bn |
| 4 |
JNJ
|
Johnson & Johnson |
555.49 Bn |
0.00 Mn |
0.00 Mn |
54.99 Bn |
| 5 |
ABBV
|
AbbVie Inc. |
373.61 Bn |
0.00 Mn |
0.00 Mn |
64.53 Bn |
| 6 |
MRK
|
Merck & Co., Inc. |
279.83 Bn |
0.00 Mn |
0.00 Mn |
49.12 Bn |
| 7 |
AMGN
|
Amgen Inc |
181.63 Bn |
0.00 Mn |
0.00 Mn |
57.32 Bn |
| 8 |
GILD
|
Gilead Sciences, Inc. |
163.98 Bn |
0.00 Mn |
0.00 Mn |
22.17 Bn |